rs2228095

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000170.3(GLDC):​c.660C>T​(p.Leu220Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0135 in 1,605,400 control chromosomes in the GnomAD database, including 2,090 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 1112 hom., cov: 32)
Exomes 𝑓: 0.0080 ( 978 hom. )

Consequence

GLDC
NM_000170.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.491

Publications

4 publications found
Variant links:
Genes affected
GLDC (HGNC:4313): (glycine decarboxylase) Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[provided by RefSeq, Jan 2010]
GLDC Gene-Disease associations (from GenCC):
  • glycine encephalopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen
  • glycine encephalopathy 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • infantile glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical glycine encephalopathy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 9-6606645-G-A is Benign according to our data. Variant chr9-6606645-G-A is described in ClinVar as Benign. ClinVar VariationId is 367202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.491 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.223 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLDCNM_000170.3 linkc.660C>T p.Leu220Leu synonymous_variant Exon 5 of 25 ENST00000321612.8 NP_000161.2 P23378

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLDCENST00000321612.8 linkc.660C>T p.Leu220Leu synonymous_variant Exon 5 of 25 1 NM_000170.3 ENSP00000370737.4 P23378

Frequencies

GnomAD3 genomes
AF:
0.0662
AC:
10074
AN:
152070
Hom.:
1089
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.226
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0287
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.0205
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.000970
Gnomad OTH
AF:
0.0522
GnomAD2 exomes
AF:
0.0206
AC:
5181
AN:
251478
AF XY:
0.0173
show subpopulations
Gnomad AFR exome
AF:
0.233
Gnomad AMR exome
AF:
0.0113
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.00245
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00111
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.00795
AC:
11558
AN:
1453212
Hom.:
978
Cov.:
28
AF XY:
0.00762
AC XY:
5516
AN XY:
723642
show subpopulations
African (AFR)
AF:
0.226
AC:
7377
AN:
32610
American (AMR)
AF:
0.0131
AC:
587
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00314
AC:
82
AN:
26074
East Asian (EAS)
AF:
0.000933
AC:
37
AN:
39656
South Asian (SAS)
AF:
0.0190
AC:
1633
AN:
85976
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.0148
AC:
85
AN:
5750
European-Non Finnish (NFE)
AF:
0.000590
AC:
652
AN:
1104972
Other (OTH)
AF:
0.0184
AC:
1105
AN:
60048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
477
953
1430
1906
2383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0667
AC:
10149
AN:
152188
Hom.:
1112
Cov.:
32
AF XY:
0.0652
AC XY:
4850
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.227
AC:
9402
AN:
41488
American (AMR)
AF:
0.0287
AC:
439
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00251
AC:
13
AN:
5180
South Asian (SAS)
AF:
0.0195
AC:
94
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.000971
AC:
66
AN:
68006
Other (OTH)
AF:
0.0564
AC:
119
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
397
794
1191
1588
1985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0578
Hom.:
551
Bravo
AF:
0.0751
Asia WGS
AF:
0.0600
AC:
209
AN:
3478
EpiCase
AF:
0.00191
EpiControl
AF:
0.00160

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycine encephalopathy Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16601880) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jun 29, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
4.2
DANN
Benign
0.57
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228095; hg19: chr9-6606645; COSMIC: COSV58682430; COSMIC: COSV58682430; API